Carregant...
Rapamycin Prevents and Breaks the Anti-CD3–Induced Tolerance in NOD Mice
OBJECTIVE: Non–Fc-binding anti-CD3–specific antibodies represent a promising therapy for preserving C-peptide production in subjects with recent-onset type 1 diabetes. However, the mechanisms by which anti-CD3 exerts its beneficial effect are still poorly understood, and it is questionable whether t...
Guardat en:
| Autors principals: | , , , , , |
|---|---|
| Format: | Artigo |
| Idioma: | Inglês |
| Publicat: |
American Diabetes Association
2009
|
| Matèries: | |
| Accés en línia: | https://ncbi.nlm.nih.gov/pmc/articles/PMC2661605/ https://ncbi.nlm.nih.gov/pubmed/19151201 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2337/db08-1432 |
| Etiquetes: |
Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!
|